Patient No.

Age (y)

LV-EF (%)

LV-EDV (mL)

LV-ESV (mL)

LV-MM (g)

gRE ⁹

Edema Ratio

Localization

of Late Enhancement

Immunohistology*

Virus

1

37

63

174

57

138

4.2

1.4

NA

0

PVB19

2

36

67

162

72

142

4.2

2.5

NA

1

PVB19

3

50

40

195

118

258

5.5

1.7

EPI: AW, SW

1

PVB19

4

35

61

157

62

125

1.1

2.1

NA

0

PVB19, HHV6

5

42

40

285

149

179

4.6

2.0

NA

1

PVB19

6

24

73

149

41

124

6.1

1.6

NA

1

PVB19

7

42

58

104

43

99

4.1

1.3

NA

0

PVB19

8

21

50

243

110

199

3.8

2.2

NA

1

PVB19

9

55

46

220

120

136

1.2

1.8

NA

0

PVB19, HHV6

10

60

53

104

48

113

2.6

1.9

NA

0

Enterovirus, PVB19

11

47

42

164

93

105

4.4

2.3

EPI: AW,SW, IW

1

PVB19

12

50

55

177

80

126

3.8

1.5

NA

1

PVB19

13

66

38

154

95

109

1.9

1.5

NA

0

PVB19

14

41

69

110

34

76

2.7

1.9

NA

0

PVB19

15

49

64

199

70

189

12.6

1.6

NA

1

HHV6

16

52

68

160

52

95

4.4

3.1

NA

1

PVB19

17

22

60

186

74

133

11.3

2.0

NA

0

PVB19

18

64

44

342

191

215

6.8

2.0

EPI: LW

0

PVB19

19

48

36

134

86

94

5.2

2.0

NA

1

PVB19

20

46

51

135

60

120

7.5

1.8

NA

1

PVB19

21

62

38

192

118

135

2.5

1.8

EPI: IW

0

PVB19

22

63

75

114

27

 80

2.1

1.9

NA

1

PVB19, HHV6

23

47

65

167

58

114

3.3

1.8

NA

0

PVB19, HHV6

24

40

67

202

67

164

8.7

2.3

NA

1

PVB19

25

40

63

275

103

115

5.1

2.3

NA

1

PVB19

26

61

65

128

45

146

4.9

2.4

TRANS: RW

1

PVB19

27

45

42

259

151

166

6.1

2.4

NA

1

PVB19

28

68

34

288

190

203

3.0

2.2

EPI: IW

1

PVB19

29

54

36

298

191

132

7.1

2.3

TRANS: SW

1

PVB19

30

41

60

114

45

126

2.6

1.9

NA

1

PVB19

31

51

45

229

126

149

4.6

2.3

INTRA: IW, LW

1

PVB19

32

42

44

181

101

141

4.3

2.0

NA

1

PVB19

33

64

45

164

90

128

3.1

2.2

NA

0

HHV6

34

45

66

155

52

135

2.9

2.2

NA

0

PVB19